For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of RXO Inc (NYSE: RXO) closed at $14.88 in the last session, down -0.60% from day before closing price of $14.97. In other words, the price has decreased by -$0.60 from its previous closing price. On the day, 1.76 million shares were traded. RXO stock price reached its highest trading level at $15.115 during the session, while it also had its lowest trading level at $14.8.
Ratios:
We take a closer look at RXO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.37.
On March 13, 2025, Truist started tracking the stock assigning a Buy rating and target price of $24.
On March 07, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $19.Deutsche Bank initiated its Hold rating on March 07, 2025, with a $19 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 14 ’25 when Szlosek Thomas A bought 7,500 shares for $16.65 per share. The transaction valued at 124,875 led to the insider holds 16,200 shares of the business.
Szlosek Thomas A bought 8,700 shares of RXO for $125,354 on May 09 ’25. The Director now owns 8,700 shares after completing the transaction at $14.41 per share. On Nov 12 ’24, another insider, Nettles Michelle, who serves as the Director of the company, bought 1,800 shares for $27.89 each. As a result, the insider paid 50,202 and bolstered with 15,185 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXO now has a Market Capitalization of 2440126720 and an Enterprise Value of 3101130240. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.44 while its Price-to-Book (P/B) ratio in mrq is 1.54. Its current Enterprise Value per Revenue stands at 0.558 whereas that against EBITDA is 22.636.
Stock Price History:
The Beta on a monthly basis for RXO is 1.55, which has changed by -0.47679323 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, RXO has reached a high of $31.98, while it has fallen to a 52-week low of $12.19. The 50-Day Moving Average of the stock is -6.89%, while the 200-Day Moving Average is calculated to be -25.94%.
Shares Statistics:
According to the various share statistics, RXO traded on average about 1.71M shares per day over the past 3-months and 2059620 shares per day over the past 10 days. A total of 163.97M shares are outstanding, with a floating share count of 160.63M. Insiders hold about 2.05% of the company’s shares, while institutions hold 105.69% stake in the company. Shares short for RXO as of 1753920000 were 6810179 with a Short Ratio of 3.99, compared to 1751241600 on 7894190. Therefore, it implies a Short% of Shares Outstanding of 6810179 and a Short% of Float of 11.62.
Earnings Estimates
RXO Inc (RXO) is presently subject to a detailed evaluation by 19.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.08, with high estimates of $0.1 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.17 and $0.13 for the fiscal current year, implying an average EPS of $0.15. EPS for the following year is $0.4, with 20.0 analysts recommending between $0.67 and $0.23.
Revenue Estimates
According to 16 analysts, the current quarter’s revenue is expected to be $1.45B. It ranges from a high estimate of $1.52B to a low estimate of $1.4B. As of the current estimate, RXO Inc’s year-ago sales were $1.04BFor the next quarter, 16 analysts are estimating revenue of $1.6B. There is a high estimate of $1.69B for the next quarter, whereas the lowest estimate is $1.49B.
A total of 19 analysts have provided revenue estimates for RXO’s current fiscal year. The highest revenue estimate was $6.06B, while the lowest revenue estimate was $5.73B, resulting in an average revenue estimate of $5.91B. In the same quarter a year ago, actual revenue was $4.55BBased on 19 analysts’ estimates, the company’s revenue will be $6.29B in the next fiscal year. The high estimate is $6.73B and the low estimate is $5.95B.
